Literature DB >> 29904303

Anabolic androgenic steroid-induced acute myocardial infarction with multiorgan failure.

Frederick J Flo1, Obiajulu Kanu2, Mohamed Teleb3, Yuefeng Chen3, Tariq Siddiqui3.   

Abstract

The abuse of anabolic androgenic steroids (AAS) has remained on the rise despite their well-known deleterious effects. We describe a case of AAS-induced multisystem failure following an extensive history of abuse in a 41-year-old bodybuilder. Furthermore, we review pertinent literature and discuss the different pathophysiologic mechanisms through which AAS affect the heart and other organs. This case points to the possibility of multiorgan involvement and severe cardiac effects of AAS abuse in young individuals who may not have any past medical history.

Entities:  

Keywords:  Acute coronary syndrome; acute myocardial infarction; anabolic steroid abuse; multiorgan failure; subclinical congestive heart failure; testosterone replacement therapy

Year:  2018        PMID: 29904303      PMCID: PMC5997056          DOI: 10.1080/08998280.2018.1460130

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  20 in total

1.  Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy.

Authors:  Kevin M Fussell; Joseph A Awad; Lorraine B Ware
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

2.  Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.

Authors:  R D Dickerman; W J McConathy; N Y Zachariah
Journal:  J Cardiovasc Risk       Date:  1997 Oct-Dec

Review 3.  Pharmacoepidemiology of anabolic androgenic steroids: a review.

Authors:  Ingemar Thiblin; Anna Petersson
Journal:  Fundam Clin Pharmacol       Date:  2005-02       Impact factor: 2.748

4.  Anabolic-androgenic steroids: medical assessment of present, past and potential users.

Authors:  A J O'Sullivan; M C Kennedy; J H Casey; R O Day; B Corrigan; A D Wodak
Journal:  Med J Aust       Date:  2000-09-18       Impact factor: 7.738

Review 5.  Effects of androgens on haemostasis.

Authors:  U H Winkler
Journal:  Maturitas       Date:  1996-07       Impact factor: 4.342

6.  Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome.

Authors:  Shinya Unai; Joseph Miessau; Pawel Karbowski; Michael Baram; Nicholas C Cavarocchi; Hitoshi Hirose
Journal:  Respir Care       Date:  2013-04-23       Impact factor: 2.258

Review 7.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

8.  Fulminant hepatic failure secondary to previously unrecognized cardiomyopathy.

Authors:  S Wiesen; K R Reddy; L J Jeffers; E R Schiff
Journal:  Dig Dis       Date:  1995 May-Jun       Impact factor: 2.404

Review 9.  Cardiovascular effects of androgenic-anabolic steroids.

Authors:  R B Melchert; A A Welder
Journal:  Med Sci Sports Exerc       Date:  1995-09       Impact factor: 5.411

Review 10.  Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.

Authors:  Paola Frati; Francesco P Busardò; Luigi Cipolloni; Enrico De Dominicis; Vittorio Fineschi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

View more
  3 in total

1.  AMI and Anabolic-Androgenic Steroids: Case Report with Systematic Review.

Authors:  Eliana M Mustafa; Idiberto José Zotarelli Filho; Victor R R Ferreira; Sofia Braile Sabino; Giovanni B Sternieri; Luiza B Verdi; Cibele O V Queiroz; Bethina C Sbardellini; Maria C V B Braile-Sternieri
Journal:  Curr Cardiol Rev       Date:  2021

2.  A Rare Case Report and Literature Review of Anabolic-Androgenic Steroids (AAS)-Induced Acute Myocardial Infarction.

Authors:  Qian Zhang; Khine S Shan; Ahmad Raza; Neelima Manda; Travis Nace
Journal:  Cureus       Date:  2020-05-28

Review 3.  Androgen-Regulated Cardiac Metabolism in Aging Men.

Authors:  Genaro Barrientos; Paola Llanos; Carla Basualto-Alarcón; Manuel Estrada
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.